| Dr Joseph Rosado, MD | |
|
3927 Rosewood Way, Orlando, FL 32808-1034 | |
| (407) 292-2200 | |
| (407) 292-8210 |
| Full Name | Dr Joseph Rosado |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 23 Years |
| Location | 3927 Rosewood Way, Orlando, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104068584 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 17750 (Puerto Rico) | Secondary |
| 208D00000X | General Practice | ACN336 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Complete Wellness Medical Center Inc | 1254306459 | 3 |
| Panacea Alliance Corp | 6002974235 | 4 |
News Archive
BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, is pleased today to announce positive preliminary results in its LIP phase III pivotal study (Lauriad® Immunocompetent Patients Study ). This multicenter randomized, double-blind, placebo controlled study compared the efficacy and safety of a single dose acyclovir Lauriad® 50mg Mucoadhesive Buccal Tablet (MBT) versus matching placebo in patients suffering from recurrent oro-facial herpes.
In a study conducted shortly before COVID-19 vaccines became available in the U.S., more than two-thirds of nursing home and assisted living staff in Indiana indicated willingness to receive a vaccine immediately or in the future.
Over a million American students misuse prescription drugs or take illegal stimulants to increase their attention span, memory, and capacity to stay awake. Such "smart drugs" become more and more popular due to peer pressure, stricter academic requirements, and the tight job market. But young people who misuse them risk long-term impairments to brain function, warn Kimberly Urban at the University of Delaware and Wen-Jun Gao at Drexel University College of Medicine, USA, in a NIH-funded review published in the open-access journal Frontiers in Systems Neuroscience.
ViPS, a General Dynamics Information Technology company, today announces its next-generation STARS Solutions suite, an advanced, comprehensive solution to assist health payers - organizations liable for healthcare coverage for plan members or beneficiaries - stop healthcare fraud, waste and abuse (FWA).
› Verified 6 days ago
| Entity Name | Complete Wellness Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134249618 PECOS PAC ID: 1254306459 Enrollment ID: O20040831001233 |
News Archive
BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, is pleased today to announce positive preliminary results in its LIP phase III pivotal study (Lauriad® Immunocompetent Patients Study ). This multicenter randomized, double-blind, placebo controlled study compared the efficacy and safety of a single dose acyclovir Lauriad® 50mg Mucoadhesive Buccal Tablet (MBT) versus matching placebo in patients suffering from recurrent oro-facial herpes.
In a study conducted shortly before COVID-19 vaccines became available in the U.S., more than two-thirds of nursing home and assisted living staff in Indiana indicated willingness to receive a vaccine immediately or in the future.
Over a million American students misuse prescription drugs or take illegal stimulants to increase their attention span, memory, and capacity to stay awake. Such "smart drugs" become more and more popular due to peer pressure, stricter academic requirements, and the tight job market. But young people who misuse them risk long-term impairments to brain function, warn Kimberly Urban at the University of Delaware and Wen-Jun Gao at Drexel University College of Medicine, USA, in a NIH-funded review published in the open-access journal Frontiers in Systems Neuroscience.
ViPS, a General Dynamics Information Technology company, today announces its next-generation STARS Solutions suite, an advanced, comprehensive solution to assist health payers - organizations liable for healthcare coverage for plan members or beneficiaries - stop healthcare fraud, waste and abuse (FWA).
› Verified 6 days ago
| Entity Name | Coastal Neurology Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457358434 PECOS PAC ID: 4082669478 Enrollment ID: O20050318000222 |
News Archive
BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, is pleased today to announce positive preliminary results in its LIP phase III pivotal study (Lauriad® Immunocompetent Patients Study ). This multicenter randomized, double-blind, placebo controlled study compared the efficacy and safety of a single dose acyclovir Lauriad® 50mg Mucoadhesive Buccal Tablet (MBT) versus matching placebo in patients suffering from recurrent oro-facial herpes.
In a study conducted shortly before COVID-19 vaccines became available in the U.S., more than two-thirds of nursing home and assisted living staff in Indiana indicated willingness to receive a vaccine immediately or in the future.
Over a million American students misuse prescription drugs or take illegal stimulants to increase their attention span, memory, and capacity to stay awake. Such "smart drugs" become more and more popular due to peer pressure, stricter academic requirements, and the tight job market. But young people who misuse them risk long-term impairments to brain function, warn Kimberly Urban at the University of Delaware and Wen-Jun Gao at Drexel University College of Medicine, USA, in a NIH-funded review published in the open-access journal Frontiers in Systems Neuroscience.
ViPS, a General Dynamics Information Technology company, today announces its next-generation STARS Solutions suite, an advanced, comprehensive solution to assist health payers - organizations liable for healthcare coverage for plan members or beneficiaries - stop healthcare fraud, waste and abuse (FWA).
› Verified 6 days ago
| Entity Name | Panacea Alliance Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326298803 PECOS PAC ID: 6002974235 Enrollment ID: O20081016000487 |
News Archive
BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, is pleased today to announce positive preliminary results in its LIP phase III pivotal study (Lauriad® Immunocompetent Patients Study ). This multicenter randomized, double-blind, placebo controlled study compared the efficacy and safety of a single dose acyclovir Lauriad® 50mg Mucoadhesive Buccal Tablet (MBT) versus matching placebo in patients suffering from recurrent oro-facial herpes.
In a study conducted shortly before COVID-19 vaccines became available in the U.S., more than two-thirds of nursing home and assisted living staff in Indiana indicated willingness to receive a vaccine immediately or in the future.
Over a million American students misuse prescription drugs or take illegal stimulants to increase their attention span, memory, and capacity to stay awake. Such "smart drugs" become more and more popular due to peer pressure, stricter academic requirements, and the tight job market. But young people who misuse them risk long-term impairments to brain function, warn Kimberly Urban at the University of Delaware and Wen-Jun Gao at Drexel University College of Medicine, USA, in a NIH-funded review published in the open-access journal Frontiers in Systems Neuroscience.
ViPS, a General Dynamics Information Technology company, today announces its next-generation STARS Solutions suite, an advanced, comprehensive solution to assist health payers - organizations liable for healthcare coverage for plan members or beneficiaries - stop healthcare fraud, waste and abuse (FWA).
› Verified 6 days ago
| Entity Name | Florida Health Care Of Brevard |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598323461 PECOS PAC ID: 7911239108 Enrollment ID: O20191021001559 |
News Archive
BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, is pleased today to announce positive preliminary results in its LIP phase III pivotal study (Lauriad® Immunocompetent Patients Study ). This multicenter randomized, double-blind, placebo controlled study compared the efficacy and safety of a single dose acyclovir Lauriad® 50mg Mucoadhesive Buccal Tablet (MBT) versus matching placebo in patients suffering from recurrent oro-facial herpes.
In a study conducted shortly before COVID-19 vaccines became available in the U.S., more than two-thirds of nursing home and assisted living staff in Indiana indicated willingness to receive a vaccine immediately or in the future.
Over a million American students misuse prescription drugs or take illegal stimulants to increase their attention span, memory, and capacity to stay awake. Such "smart drugs" become more and more popular due to peer pressure, stricter academic requirements, and the tight job market. But young people who misuse them risk long-term impairments to brain function, warn Kimberly Urban at the University of Delaware and Wen-Jun Gao at Drexel University College of Medicine, USA, in a NIH-funded review published in the open-access journal Frontiers in Systems Neuroscience.
ViPS, a General Dynamics Information Technology company, today announces its next-generation STARS Solutions suite, an advanced, comprehensive solution to assist health payers - organizations liable for healthcare coverage for plan members or beneficiaries - stop healthcare fraud, waste and abuse (FWA).
› Verified 6 days ago
| Entity Name | Total Care Medical Centers Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285212050 PECOS PAC ID: 1052716875 Enrollment ID: O20210817002828 |
News Archive
BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, is pleased today to announce positive preliminary results in its LIP phase III pivotal study (Lauriad® Immunocompetent Patients Study ). This multicenter randomized, double-blind, placebo controlled study compared the efficacy and safety of a single dose acyclovir Lauriad® 50mg Mucoadhesive Buccal Tablet (MBT) versus matching placebo in patients suffering from recurrent oro-facial herpes.
In a study conducted shortly before COVID-19 vaccines became available in the U.S., more than two-thirds of nursing home and assisted living staff in Indiana indicated willingness to receive a vaccine immediately or in the future.
Over a million American students misuse prescription drugs or take illegal stimulants to increase their attention span, memory, and capacity to stay awake. Such "smart drugs" become more and more popular due to peer pressure, stricter academic requirements, and the tight job market. But young people who misuse them risk long-term impairments to brain function, warn Kimberly Urban at the University of Delaware and Wen-Jun Gao at Drexel University College of Medicine, USA, in a NIH-funded review published in the open-access journal Frontiers in Systems Neuroscience.
ViPS, a General Dynamics Information Technology company, today announces its next-generation STARS Solutions suite, an advanced, comprehensive solution to assist health payers - organizations liable for healthcare coverage for plan members or beneficiaries - stop healthcare fraud, waste and abuse (FWA).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Rosado, MD Po Box 636987, Cincinnati, OH 45263-6987 Ph: (352) 854-0681 | Dr Joseph Rosado, MD 3927 Rosewood Way, Orlando, FL 32808-1034 Ph: (407) 292-2200 |
News Archive
BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, is pleased today to announce positive preliminary results in its LIP phase III pivotal study (Lauriad® Immunocompetent Patients Study ). This multicenter randomized, double-blind, placebo controlled study compared the efficacy and safety of a single dose acyclovir Lauriad® 50mg Mucoadhesive Buccal Tablet (MBT) versus matching placebo in patients suffering from recurrent oro-facial herpes.
In a study conducted shortly before COVID-19 vaccines became available in the U.S., more than two-thirds of nursing home and assisted living staff in Indiana indicated willingness to receive a vaccine immediately or in the future.
Over a million American students misuse prescription drugs or take illegal stimulants to increase their attention span, memory, and capacity to stay awake. Such "smart drugs" become more and more popular due to peer pressure, stricter academic requirements, and the tight job market. But young people who misuse them risk long-term impairments to brain function, warn Kimberly Urban at the University of Delaware and Wen-Jun Gao at Drexel University College of Medicine, USA, in a NIH-funded review published in the open-access journal Frontiers in Systems Neuroscience.
ViPS, a General Dynamics Information Technology company, today announces its next-generation STARS Solutions suite, an advanced, comprehensive solution to assist health payers - organizations liable for healthcare coverage for plan members or beneficiaries - stop healthcare fraud, waste and abuse (FWA).
› Verified 6 days ago
Dilcia I Hernandez Santana, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 8803 Futures Dr Ste 9, Orlando, FL 32819 Phone: 407-240-2361 Fax: 407-345-8895 | |
Baha Aldeen Bani Fawwaz, MBBS General Practice Medicare: Medicare Enrolled Practice Location: 2501 N Orange Ave Ste 235, Orlando, FL 32804 Phone: 407-303-7270 | |
Dr. Nhung Thi Tran, M.D General Practice Medicare: Not Enrolled in Medicare Practice Location: 4000 Central Florida Blvd, Orlando, FL 32816 Phone: 407-823-2098 Fax: 407-823-6932 | |
Dr. Marcos Antonio Rivera Roman, MD General Practice Medicare: Medicare Enrolled Practice Location: 1130 S Semoran Blvd Ste Bandc, Orlando, FL 32807 Phone: 407-382-1376 Fax: 321-235-3232 | |
Abhishek Mishra, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 7620 Lake Underhill Rd, Orlando, FL 32822 Phone: 321-235-0692 Fax: 321-235-0694 | |
Osmany Lazaro Rodriguez Herrada, MD General Practice Medicare: Medicare Enrolled Practice Location: 811 N Nowell St, Orlando, FL 32808 Phone: 407-259-2383 Fax: 407-363-3884 | |
Dr. Dariusz Grzegorz Mydlarz, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 6336 W Colonial Dr, Orlando, FL 32818 Phone: 407-219-5200 Fax: 321-281-8700 |